3-{1-[2-(4-chlorophenyl)acetyl]piperidin-4-yl}-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one

Catalog No. :
ACIEOJ108
CAS No. :
1775426-69-1
Molecular Formula :
C22H22ClFN4O2
Molecular Weight :
428.89

IUPAC Name:5-(1-(2-(4-chlorophenyl)acetyl)piperidin-4-yl)-4-(4-fluorobenzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

3-{1-[2-(4-chlorophenyl)acetyl]piperidin-4-yl}-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{1-[2-(4-chlorophenyl)acetyl]piperidin-4-yl}-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one
IUPAC Name5-(1-(2-(4-chlorophenyl)acetyl)piperidin-4-yl)-4-(4-fluorobenzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
MDL No.MFCD28506577
Molecular FormulaC22H22ClFN4O2
Molecular Weight428.89
SMILESO=C1N(CC2=CC=C(F)C=C2)C(C3CCN(C(CC4=CC=C(Cl)C=C4)=O)CC3)=NN1
InChI KeyNBNWXEUNDDOUJY-UHFFFAOYSA-N
Synonym3-{1-[2-(4-chlorophenyl)acetyl]piperidin-4-yl}-4-[(4-fluorophenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one;3H-1,2,4-Triazol-3-one, 5-[1-[2-(4-chlorophenyl)acetyl]-4-piperidinyl]-4-[(4-fluorophenyl)methyl]-2,4-dihydro-
CAS No.1775426-69-1

Synthetic Route by SureRoute

1. ACIEOJ108 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDKIY807 route compound structure diagram
    ACDKIY8071878-66-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIEOJ108 route product structure diagram
    ACIEOJ1081775426-69-1
Inquiry

2. ACIEOJ108 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIEOJ108 route product structure diagram
    ACIEOJ1081775426-69-1
Inquiry

Comments (0)